SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
CeloNova BioSciences Release: 12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions